Biogen Idec Senior VP International Business on Expanding Opportunities And Lessons Learned In Asia
This article was originally published in PharmAsia News
Executive SummaryBiogen Idec's strategy in emerging markets is not likely to change under the company's new CEO George Scangos, according to Senior VP International Business Gunther Winkler
You may also be interested in...
"With A Molecule That Is A Million Times Larger Than A Small Molecule, So Many Things Can Go Wrong," Says Biogen Idec Asia Operations Head Gunther Winkler
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).